A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity
(By Juliette Cubanski, Tricia Neuman, Nolan Sroczynski, and Anthony Damico for The Kaiser Family Foundation Published: Apr 24, 2024) The
Read More
Part D/Prescription Drugs
CDC probe into fake Botox grows: 5 notes
(By Erica Carbajal for Becker’s Hospital Review) Health officials are now investigating at least 22 reports of harmful reactions linked
Read MoreFeds to investigate integrated Part D plans, PBMs
(By Rylee Wilson for Becker’s Hospital Review) HHS’ Office of Inspector General will investigate the impact of vertically integrated Medicare
Read MoreA cheap drug may slow down aging. A study will determine if it works
(By Allison Aubrey for NPR) A drug taken by millions of people to control diabetes may do more than lower
Read MoreAdults may need whooping cough booster as cases rise: CDC
(By Erica Carbajal for Becker’s Hospital Review) In recent months, parts of the U.S. have reported outbreaks of pertussis, or
Read MoreGaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency
(By Jeannie Fuglesten Biniek, Meredith Freed, and Tricia Neuman for The Kaiser Family Foundation Published: Apr 10, 2024) The Centers
Read MoreTop PBMs by 2023 market share
(By Mackenzie Bean for Becker’s Hospital Review) Three pharmacy benefit managers accounted for nearly 80% of all prescription claims handled
Read MoreCMS finalizes 2025 Medicare Advantage rule: 11 key updates
(By Jakob Emerson for Becker’s Hospital Review) CMS issued its final 2025 Medicare Advantage and Part D rule April 4,
Read MoreOzempic predecessor may slow Parkinson’s progression, new study shows
By Erica Carbajal for Becker’s Hospital Review on April 4, 2024 A small study has found lixisenatide, a GLP-1 made
Read MoreBiden Is Right About $35 Insulin Cap but Exaggerates Prior Costs for Medicare Enrollees
By Samantha Putterman, Politifact for KFF Health News on April 5, 2024 The cost of insulin in the United States
Read More